GlaxoSmithKline

Do more, feel better, live longer
 

GSK in focus

COPD: beyond a
'smokers cough'

Apart from cancer, heart attack, AIDS, malaria
and tuberculosis, can you name a disease
that kills, on average, one person every
10 seconds?

The answer is chronic obstructive
pulmonary disease (COPD). It's not
'smoker's cough', as commonly thought,
but rather an under-diagnosed, life-threatening lung disease.

To mark World COPD on 19 November, we look at this
relatively unknown disease and the treatments available.

GSK worldwide


Our products


 

Corporate press releases

[an error occurred while processing this directive] [an error occurred while processing this directive]

12 November 2008
GSK commences tender offer to acquire Genelabs Technologies, Inc.

11 November 2008
GSK proposes to close Dartford manufacturing site in the UK by 2013

10 November 2008
GSK and Xenoport announce plans to withdraw and resubmit new drug application requesting approval of Solzira™ for restless legs syndrome

More press releases

RSS Subscribe to press release RSS feed
What are RSS feeds?

Investors

LSE
1222p
-21.00

19 Nov 2008 11:40am GMT
NYSE
37.20
0.00

19 Nov 2008 closed
London Stock Exchange price updated every minute. Provided by
Hemscott Group Limited